International Research Foundation for RSD/CRPS

 

 

Interview with Patient after

High-Dose Ketamine Coma

(38-Minute Free Video)

 

Translation Selections:

 

Chinese

Español  

Français

Japanese

 

 

The Food and Drug Administration (FDA) in the United States has approved ketamine as a sole anesthetic agent for general anesthesia and for the treatment of

breakthrough pain.

In this video presentation, Elizabeth Jones recounts how her recent participation in the high dose ketamine "coma" trial in June 2005 has given her a "second lease" on life.

In the following video Elizabeth recalls the ordeal of the clinical trial in detail. Regardless of audience, the release of this video will assist in making informed

decisions about high dose

ketamine research.

 

 SELECT BANDWIDTH FOR 38-MINUTE VIDEO:

 

Broadband (High)   ~ 352K

Broadband (Low)   ~244K

Transcript of Video

 

 

Click Here For CNN Report On Ketamine Coma

 

For more information on RSD / CRPS, please read the Third Edition of the Clinical Practice Guidelines

GUIDELINES

The Guidelines and the above video were subject to peer review by the Foundation's Scientific

Advisory Committee

COMMITTEE

 

 

Updates:

1. On September 24, 2006, Elizabeth gave birth to her first child:

PHOTOS

2. April 25, 2009:

PHOTOS

3. Five years after the ketamine coma procedure, Elizabeth Jones looks forward to the birth of her second child….. learn more from a 5-minute video:

VIDEO

4. January 12, 2011, Elizabeth gives birth to her second child:

PHOTOS

5. June 24, 2011, Elizabeth undergoes outpatient ketamine infusion:

HD VIDEO

 

 

 

 


HOME  |  MENU  | CONTACT US

The International Research Foundation for RSD / CRPS is a
501(c)(3) (not-for-profit) organization in the United States of America.


Copyright © 2005 International Research Foundation for RSD / CRPS.
All rights reserved.
For permission to reprint any information on the
web site, please contact the Foundation.